Evidence map›Paper›PMID 22950383›Full record

ReviewCurrent molecular medicine2013

NFAT gene family in inflammation and cancer.

M-G Pan, Y Xiong, F Chen

Abstract readReview
In one paragraph

Review in Current molecular medicine, 2013. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 108 papers.

0numbers the graph read from it
0cells of the map it votes in
108citing papers in PubMed
8.5field-weighted citation impact, top 2% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

108 citing papers in PubMed, 200 citations in OpenAlex.

  1. NChemical biology & drug design · 2026
    Article
  2. Article
  3. Article
  4. Review
  5. BPGM shapes NFAT5-driven cellular responses.Cellular and molecular life sciences : CMLS · 2026
    Article
  6. Review
  7. Synergistic roles of NFATc1 and c-Jun in immunomodulation.Biochemistry and biophysics reports · 2025
    Review
  8. Article
  9. Review
  10. Article
  11. Review
  12. Augmentation of Solid Tumor Immunotherapy With IL-12.The journal of gene medicine · 2024
    Review
  13. Article
  14. Article
  15. Advances in IL-7 Research on Tumour Therapy.Pharmaceuticals (Basel, Switzerland) · 2024
    Review
  16. Article
  17. Article
  18. Article
  19. Transcriptional rewiring in CD8Frontiers in immunology · 2024
    Review
  20. Article

48 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors at 3 institutions in 2 countries.

M-G PanDivision of Oncology and Hematology, Kaiser Permanente Medical Center, Santa Clara, CA 95051, USA. Minggui.Pan@kp.org
Y Xiong
F Chen
Kaiser Permanente Santa Clara Medical Center · USRenal Association · GBStanford University · US

Funding

NFAT SIGNALING IN GLOMERULOSCLEROSISR01DK087960 · NIDDK · WASHINGTON UNIVERSITY · PI CHEN, FENG · 2010 to 2014
$1.6M
GENETIC DETERMINANTS IN KIDNEY AND URINARY TRACT DEFECTSR01DK081592 · NIDDK · WASHINGTON UNIVERSITY · PI CHEN, FENG · 2009 to 2012
$1.4M
NIDDK NIH HHS DK081592NIDDK NIH HHS DK087960NIDDK NIH HHS R01 DK081592NIDDK NIH HHS R01 DK087960
6 · The paper itself

Abstract

Calcineurin-NFAT signaling is critical for numerous aspects of vertebrate function during and after embryonic development. Initially discovered in T cells, the NFAT gene family, consisting of five members, regulates immune system, inflammatory response, angiogenesis, cardiac valve formation, myocardial development, axonal guidance, skeletal muscle development, bone homeostasis, development and metastasis of cancer, and many other biological processes. In this review we will focus on the NFAT literature relevant to the two closely related pathological systems: inflammation and cancer.

Indexed as

Multigene FamilyHumansInflammationNeoplasmsNFATC Transcription FactorsSignal TransductionNFATC Transcription Factors

Identifiers

PMID22950383
PMCPMC3694398
OpenAlexW2107614036

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.